The FDA’s database shows that the Lactulose product (brand name Lactulose) is an oral and rectal solution marketed under product number 001. It contains the active ingredient Lactulose at a strength of 10 g/15 mL and is not a reference drug.
According to the FDA entry, the marketing status of this product is listed as discontinued. The application is identified by NDA017906 and the sponsor is Solvay.
Regulatory UpdatesSep 28, 2026•1 min read
FDA Discontinues Lactulose Oral/Rectal Solution (NDA017906)
The FDA has listed the Lactulose oral and rectal solution (product #001) as discontinued under NDA017906, sponsored by Solvay.
Compiled by the PharmaCountry team · Source: FDA.gov
Ratings
(0)
(0)
(0)
(0)
(0)
More articles
View all insightsResearch & Reports
Global Finished Dosage Manufacturing Landscape 2026
Oct 5, 2026
Regulatory UpdatesKorea Korus hit with 1‑month manufacturing suspension over missing post‑marketing safety test
Sep 28, 2026
AnalysisPharma distributors set delivery cut‑offs ahead of Chuseok holiday (Sep 21‑23)
Sep 28, 2026
Leave your rating